Related Experiment Video

Updated: Aug 20, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

[Influence of chronic HBV infection and interferon therapy on somatic development of children]

Irma Kacprzak-Bergman1, Paweł Bergman, Izabela Zaleska

  • 1Katedra i Klinika Chorób Zakaźnych Dzieci, Akademia Medyczna, Bujwida 44, 50-345 Wrocław, Poland.

Medycyna Wieku Rozwojowego
|November 24, 2004
PubMed

Insights

Interferon alpha (IFN) treatment for chronic hepatitis B in children does not permanently affect body mass or height. Early treatment of chronic hepatitis B infection is crucial to prevent growth retardation in children.

Area of Science:

  • Pediatrics
  • Hepatology
  • Endocrinology

Background:

  • Interferon alpha (IFN) is a primary treatment for pediatric chronic hepatitis B.
  • The long-term developmental impact of IFN therapy in children remains a subject of discussion.

Purpose of the Study:

  • To assess the body mass and height of children following interferon therapy for chronic hepatitis B.
  • To evaluate the influence of chronic HBV infection on these growth parameters.

Main Methods:

  • The study included 64 children with chronic hepatitis B (48 treated with IFN, 22 untreated) and a control group of 873 children.
  • Statistical analysis involved scatter plots and chi-square tests to compare growth parameters across groups.

Main Results:

  • No statistically significant differences in body mass or height distribution were observed between treated and untreated children.
  • Approximately 60% of affected boys and 43% of affected girls exhibited lower weight than the population mean.
  • Around 40% of affected boys and 37% of affected girls were shorter than the control group's mean height.

Conclusions:

  • Interferon alpha therapy for pediatric chronic hepatitis B is not associated with permanent disturbances in body mass or height.
  • Prompt treatment of chronic hepatitis B in children is essential to mitigate potential growth retardation.
Abstract

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...